APA

Morodomi Y., Takenoyama M., Inamasu E., Toyozawa R., Kojo M., Toyokawa G., Shiraishi Y., Takenaka T., Hirai F., Yamaguchi M., Taguchi K., Seto T., Sugio K. & Ichinose Y. (20140821). Non-small cell lung cancer patients with EML4-ALK fusion gene are insensitive to cytotoxic chemotherapy. : Anticancer research.

Chicago

Morodomi Yosuke, Takenoyama Mitsuhiro, Inamasu Eiko, Toyozawa Ryo, Kojo Miyako, Toyokawa Gouji, Shiraishi Yoshimasa, Takenaka Tomoyoshi, Hirai Fumihiko, Yamaguchi Masafumi, Taguchi Kenichi, Seto Takashi, Sugio Kenji and Ichinose Yukito. 20140821. Non-small cell lung cancer patients with EML4-ALK fusion gene are insensitive to cytotoxic chemotherapy. : Anticancer research.

Harvard

Morodomi Y., Takenoyama M., Inamasu E., Toyozawa R., Kojo M., Toyokawa G., Shiraishi Y., Takenaka T., Hirai F., Yamaguchi M., Taguchi K., Seto T., Sugio K. and Ichinose Y. (20140821). Non-small cell lung cancer patients with EML4-ALK fusion gene are insensitive to cytotoxic chemotherapy. : Anticancer research.

MLA

Morodomi Yosuke, Takenoyama Mitsuhiro, Inamasu Eiko, Toyozawa Ryo, Kojo Miyako, Toyokawa Gouji, Shiraishi Yoshimasa, Takenaka Tomoyoshi, Hirai Fumihiko, Yamaguchi Masafumi, Taguchi Kenichi, Seto Takashi, Sugio Kenji and Ichinose Yukito. Non-small cell lung cancer patients with EML4-ALK fusion gene are insensitive to cytotoxic chemotherapy. : Anticancer research. 20140821.